Cord blood banking is when a baby's umbilical cord blood is collected and stored after delivery. Cord blood is what's left inside a baby's umbilical cord after its cut. Umbilical cord blood is rich in stem cells. Stem cells are valuable because they help treat many life-threatening diseases. For most healthy people, making stem cells isn't a problem. Unfortunately, some people don't make enough healthy stem cells due to a severe medical condition or disease. The stem cells from cord blood can be lifesaving for these people. Cord blood contains a special type of stem cell found in bone marrow that can help strengthen the immune system. These cells are unique because they can mature into different types of blood cells. Cord blood banks exist to collect and store these stem cells. Healthcare providers use cord blood stem cells for transplants in sick people or for medical research. Cord blood banking is entirely optional. People who need stem cell transplants benefit from a baby's cord blood. Once stem cells are transplanted into those individuals, they help make new, healthy cells. Stem cell transplants help people with: Cancers like leukemia and lymphoma; Bone marrow diseases requiring a transplant; Anemia like sickle cell disease; certain immune system disorders. Researchers are studying cord blood to see how it can help treat other life-threatening conditions like Parkinson's disease and diabetes. Cord blood banks analyze and process the cord blood it receive. It assigns the blood certain characteristics. When these characteristics are matched for donor and receiver, donated stem cells can help a sick person's immune system fight diseases.

Market Dynamics

Increasing prevalence of chronic diseases, mergers and acquisitions by key market players, and increasing number of blood donor centers are expected to drive the global cord blood banking services market’s growth. For instance, in April 2020, BioIVT LLC a provider of research models and services for drug and diagnostic development, started its new blood donor center on the Tufts University campus in Medford, Massachusetts, U.S., to support academic and pharmaceutical researchers involved in COVID-19, cell, and gene therapy research.

Key features of the study:

• This report provides an in-depth analysis of the global cord blood banking services market  and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cord blood banking services market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include China Cord Blood Corporation, Cord Blood America, Inc., CBR Systems, Inc., Cordlife Group Ltd., Cryo-Cell International, Inc., StemCyte, Inc., Americord Registry, Cryo-Save Group AV, NeoStem, Inc., Blood Centers of America, and ViaCord, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global cord blood banking services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cord blood banking services market

Detailed Segmentation:

• Global Cord Blood Banking Services Market, By Type:
  • Public Cord Blood Banking Services
  • Private Cord Blood Banking Services
• Global Cord Blood Banking Services Market, By Region:
  • North America
    
    • U.S.
    • Canada
  • Latin America
    
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    
    • North Africa
    • Central Africa
    • South Africa
• Company Profiles
  • China Cord Blood Corporation
  • Cord Blood America, Inc.
  • CBR Systems, Inc.
  • Cordlife Group Ltd.
  • Cryo-Cell International, Inc.
  • StemCyte, Inc.
  • Americord Registry
  • Cryo-Save Group AV
  • NeoStem, Inc.
  • Blood Centers of America
  • ViaCord, Inc.